Northern Trust’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $156K | Buy |
49,081
+1,199
| +3% | +$4.7K | ﹤0.01% | 4011 |
|
|
2025
Q4 | $206K | Buy |
47,882
+5,499
| +13% | +$49.3K | ﹤0.01% | 3979 |
|
|
2025
Q3 | $1.65M | Buy |
42,383
+11,975
| +39% | +$341K | ﹤0.01% | 3137 |
|
|
2025
Q2 | $709K | Buy |
+30,408
| New | +$719K | ﹤0.01% | 3533 |
|
|
2024
Q4 | – | Sell |
-2,370
| Closed | -$26.3K | – | 4498 |
|
|
2024
Q3 | $26.3K | Sell |
2,370
-7,900
| -77% | -$92.6K | ﹤0.01% | 4308 |
|
|
2024
Q2 | $95.4K | Sell |
10,270
-586
| -5% | -$14K | ﹤0.01% | 4064 |
|
|
2024
Q1 | $356K | Sell |
10,856
-28
| -0.3% | -$726 | ﹤0.01% | 3679 |
|
|
2023
Q4 | $291K | Sell |
10,884
-705
| -6% | -$29.2K | ﹤0.01% | 3737 |
|
|
2023
Q3 | $701K | Buy |
11,589
+213
| +2% | +$20K | ﹤0.01% | 3409 |
|
|
2023
Q2 | $1.16M | Sell |
11,376
-8,313
| -42% | -$1.15M | ﹤0.01% | 3302 |
|
|
2023
Q1 | $3.48M | Sell |
19,689
-599
| -3% | -$201K | ﹤0.01% | 2669 |
|
|
2022
Q4 | $7.84M | Buy |
20,288
+142
| +0.7% | +$53.9K | ﹤0.01% | 2173 |
|
|
2022
Q3 | $6.79M | Buy |
20,146
+1,622
| +9% | +$588K | ﹤0.01% | 2260 |
|
|
2022
Q2 | $6.09M | Buy |
18,524
+3,212
| +21% | +$1.13M | ﹤0.01% | 2375 |
|
|
2022
Q1 | $6.7M | Sell |
15,312
-499
| -3% | -$205K | ﹤0.01% | 2400 |
|
|
2021
Q4 | $6.93M | Sell |
15,811
-625
| -4% | -$314K | ﹤0.01% | 2502 |
|
|
2021
Q3 | $9.14M | Sell |
16,436
-82
| -0.5% | -$41.1K | ﹤0.01% | 2344 |
|
|
2021
Q2 | $8.49M | Buy |
16,518
+2,882
| +21% | +$1.83M | ﹤0.01% | 2487 |
|
|
2021
Q1 | $10.7M | Sell |
13,636
-990
| -7% | -$678K | ﹤0.01% | 2246 |
|
|
2020
Q4 | $7.97M | Sell |
14,626
-178
| -1% | -$93.3K | ﹤0.01% | 2401 |
|
|
2020
Q3 | $6.78M | Sell |
14,804
-992
| -6% | -$576K | ﹤0.01% | 2344 |
|
|
2020
Q2 | $9.72M | Buy |
15,796
+1,065
| +7% | +$588K | ﹤0.01% | 2117 |
|
|
2020
Q1 | $7M | Buy |
14,731
+249
| +2% | +$135K | ﹤0.01% | 2112 |
|
|
2019
Q4 | $8.4M | Sell |
14,482
-251
| -2% | -$176K | ﹤0.01% | 2286 |
|
|
2019
Q3 | $9.7M | Buy |
14,733
+2,854
| +24% | +$2.37M | ﹤0.01% | 2165 |
|
|
2019
Q2 | $9.19M | Buy |
11,879
+45
| +0.4% | +$31.6K | ﹤0.01% | 2208 |
|
|
2019
Q1 | $8.36M | Buy |
11,834
+51
| +0.4% | +$30.5K | ﹤0.01% | 2261 |
|
|
2018
Q4 | $5.51M | Buy |
11,783
+23
| +0.2% | +$14.8K | ﹤0.01% | 2442 |
|
|
2018
Q3 | $10.1M | Buy |
11,760
+2,411
| +26% | +$1.74M | ﹤0.01% | 2247 |
|
|
2018
Q2 | $6.45M | Buy |
9,349
+465
| +5% | +$236K | ﹤0.01% | 2542 |
|
|
2018
Q1 | $3.96M | Buy |
8,884
+94
| +1% | +$45.6K | ﹤0.01% | 2723 |
|
|
2017
Q4 | $3.87M | Sell |
8,790
-315
| -3% | -$144K | ﹤0.01% | 2759 |
|
|
2017
Q3 | $4.49M | Sell |
9,105
-36
| -0.4% | -$18K | ﹤0.01% | 2696 |
|
|
2017
Q2 | $5.06M | Buy |
9,141
+2,293
| +33% | +$1.45M | ﹤0.01% | 2637 |
|
|
2017
Q1 | $4.53M | Buy |
6,848
+439
| +7% | +$235K | ﹤0.01% | 2608 |
|
|
2016
Q4 | $2.14M | Sell |
6,409
-192
| -3% | -$61.6K | ﹤0.01% | 3051 |
|
|
2016
Q3 | $1.98M | Buy |
6,601
+583
| +10% | +$126K | ﹤0.01% | 3075 |
|
|
2016
Q2 | $1.04M | Sell |
6,018
-351
| -6% | -$76.4K | ﹤0.01% | 3335 |
|
|
2016
Q1 | $1.43M | Sell |
6,369
-44
| -0.7% | -$13.1K | ﹤0.01% | 3136 |
|
|
2015
Q4 | $3.89M | Buy |
6,413
+811
| +14% | +$445K | ﹤0.01% | 2622 |
|
|
2015
Q3 | $2.88M | Buy |
5,602
+3,658
| +188% | +$2.45M | ﹤0.01% | 2818 |
|
|
2015
Q2 | $850K | Buy |
1,944
+173
| +10% | +$66.9K | ﹤0.01% | 3405 |
|
|
2015
Q1 | $641K | Hold |
1,771
| – | – | ﹤0.01% | 3544 |
|
|
2014
Q4 | $636K | Buy |
1,771
+55
| +3% | +$17.7K | ﹤0.01% | 3492 |
|
|
2014
Q3 | $519K | Buy |
1,716
+154
| +10% | +$63.2K | ﹤0.01% | 3556 |
|
|
2014
Q2 | $957K | Buy |
1,562
+1,000
| +178% | +$538K | ﹤0.01% | 3409 |
|
|
2014
Q1 | $377K | Buy |
+562
| New | +$332K | ﹤0.01% | 3619 |
|
Other funds holding TVRD
SPC
VCM
AFG
SAM
DWAM
Northern Trust's TVRD Position: Q1 2026 in Review
Northern Trust increased its Tvardi Therapeutics (TVRD) stake by 2.5% in Q1 2026, buying an estimated $4.7K and bringing the position to 49,081 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #4011.
Northern Trust first reported a position in TVRD in Q1 2014 and has held it in 47 quarters since. The position peaked at $10.7M in Q1 2021. 67 funds tracked by Wall St. Rank hold TVRD as of Q1 2026.
- Northern Trust held 49,081 shares of Tvardi Therapeutics worth $156K as of Q1 2026.
- Northern Trust bought 1,199 Tvardi Therapeutics shares in Q1 2026, an estimated $4.7K.
- Tvardi Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4011 holding.
- Northern Trust first reported a position in Tvardi Therapeutics in Q1 2014 and has held it in 47 quarters since.
- Northern Trust's Tvardi Therapeutics position peaked at $10.7M in Q1 2021.
- 67 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.